Essen Coronary Artery Disease Registry

NCT04196712 · tracked via the Priya Life Science Germany tracker

Sponsor

University Hospital, Essen

Phase

Observational

Started

2019-09-01

Last updated

2024-12-24

Condition(s) studied

Coronary Artery Disease

Study summary

The ECAD registry is a registry of patients undergoing coronary angiography at the West German Heart and Vascular Center. The registry anticipates to determine predictors of patient outcome after coronary angiography.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients undergoing invasive coronary angiography at the West German Heart and Vascular Center Exclusion Criteria: * None

Primary outcome measure(s)

All-cause mortality — through study completion, an average of 3 year
Mortality of any cause

Trial sites (1)

Facility	City	Region	Status
University Hospital Essen	Essen	North Rhine-Westphalia	Recruiting

More University Hospital, Essen trials in Germany

Tourniquet-Test in HHT Active, not recruiting

Essen Amyloidosis Registry Recruiting

Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 Glioma Recruiting

Body Donation in HHT Recruiting

Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis Recruiting

Other trials for the same condition

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial Active, not recruiting

The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial Active, not recruiting

Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis Recruiting

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions Recruiting

SeQuent® SCB "All Comers" Post Market Clinical Follow-up (PMCF) Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04196712 on ClinicalTrials.gov ↗ ← All trials in Germany